首页> 外文期刊>British Journal of Medicine and Medical Research >Validation of CK-19 and HBME-1 Expression Pattern in FNACs to Supplement Morphological Evaluation for Preoperative Diagnosis of Thyroid Lesions
【24h】

Validation of CK-19 and HBME-1 Expression Pattern in FNACs to Supplement Morphological Evaluation for Preoperative Diagnosis of Thyroid Lesions

机译:验证FNAC中CK-19和HBME-1表达模式的补充形态学评价甲状腺病变的术前诊断。

获取原文
           

摘要

Aim: Fine Needle Aspiration Cytology is the cost effective, quick and minimally invasive method for the initial evaluation of thyroid nodule. But it poses a diagnostic challenge in differentiating benign follicular adenoma from follicular carcinoma and follicular variant of papillary carcinoma as they have similar cytological appearance. Present study focused on the identification of a biological marker for the differential diagnosis of thyroid malignancy in indeterminate cases. Place and Duration of the Study: Division of cancer Research, Regional Cancer Centre, Kerala, India, between August 2009 to September 2014. Methodology: Immunohistochemistry was performed using Ret (Rearranged during transfection), Hector Battifora Mesothelial Cell Antigen-1 (HBME-1), Cytokeratin-19 (CK-19), Keratan sulphate (KS), Thyroid peroxidase (TPO), Estrogen receptor (ER) and Progesterone receptor (PR) on cell block prepared from FNA material and corresponding tissue sections on 153 samples. Western blot analysis of ER and PR was performed in surgically excised fresh tissue specimens. Results: The present study found that HBME-1 is highly significant (P < .001) for the differential diagnosis with a diagnostic accuracy of 95.96%. Ret immunostaining may serve as good indicator of PTC whereas its sensitivity is very low in other lesions. The diagnostic accuracy of CK-19 was 90.91%. Intense positive staining of TPO was noted in majority of follicular epithelial cells of benign lesions (42.42%). Females had an increased prevalence in our study population so we examined the estrogen and progesterone receptors status in thyroid lesions. The specificity of KS, ER and PR are very low for the differentiation of adenoma from carcinomas of the thyroid. Conclusion: Present study found that the combination of two markers may give a more accurate way in the differentiation of thyroid nodules in problematic cases. So we suggest morphological evaluation along with immunocytochemistry of HBME-1 and CK19 can help the differential diagnosis of thyroid lesions in FNAs.
机译:目的:细针穿刺细胞学检查是一种经济有效,快速且微创的甲状腺结节初始评估方法。但这在将良性滤泡性腺瘤与滤泡癌和乳头状癌的滤泡变体区分开来方面提出了诊断挑战,因为它们具有相似的细胞学外观。目前的研究侧重于确定不确定病例中甲状腺恶性肿瘤的生物标志物。研究的地点和持续时间:2009年8月至2014年9月,印度喀拉拉邦地区癌症中心癌症研究部。方法:使用Ret(转染过程中重新排列),Hector Battifora间皮细胞抗原1(HBME- 1)细胞模板上的细胞角蛋白19(CK-19),硫酸角质素(KS),甲状腺过氧化物酶(TPO),雌激素受体(ER)和孕激素受体(PR)和153个样品的相应组织切片。 ER和PR的蛋白质印迹分析是在手术切除的新鲜组织标本中进行的。结果:本研究发现HBME-1对于鉴别诊断非常重要(P <.001),诊断准确率为95.96%。视网膜免疫染色可以作为PTC的良好指标,而在其他病变中其敏感性非常低。 CK-19的诊断准确性为90.91%。在大多数良性病变的滤泡上皮细胞中均观察到强阳性的TPO染色(42.42%)。女性在我们的研究人群中患病率增加,因此我们检查了甲状腺病变中雌激素和孕激素受体的状态。 KS,ER和PR对从甲状腺癌中分化出腺瘤的特异性非常低。结论:目前的研究发现,两种标记物的组合可能为疑难病例的甲状腺结节的分化提供更准确的方法。因此,我们建议形态学评估以及HBME-1和CK19的免疫细胞化学可以帮助鉴别FNA中的甲状腺病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号